ℹ️ This website is strictly for educational and informational purposes. We are not medical professionals and cannot provide dosage advice or medical guidance.
⚠️ Please consult with a qualified healthcare provider before using any substances.
Retatrutide vs Tirzepatide: What Early Research Shows About the Next Generation of Peptides
Peptide-based therapies are transforming metabolic research. Tirzepatide (Mounjaro) has already proven itself as a ground-breaking dual GLP-1/GIP agonist, while Retatrutide is emerging as the “next frontier” with triple receptor activity (GLP-1, GIP, and glucagon). But how do these two peptides compare, and what does current…